CT Score for Assessing Bowel Damage in Acute Mesenteric Ischemia
The Feasibility of a Radiological Score Based on CT Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia
Recruiting
Observational Study
Acute Mesenteric Ischemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
University of Tartu · Other
Who this trial is looking for
This trial is looking for adults with acute mesenteric ischemia to see if a special way of reading CT scans can help identify salvageable bowel. Participants will have a CT scan of their abdomen with contrast media to assess the condition of their bowel.
Are You a Good Fit for This Trial?
You may be able to join if
I am a participant in the AMESI study
I have confirmed or suspected acute mesenteric ischemia
I have a CT scan of my entire abdomen using contrast media
You may not be able to join if
I have a CT scan that did not use contrast media
I have a CT scan that only covered part of my abdomen
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Computed tomography (CT) is the standard modality for scanning patients with critical acute abdominal conditions, including suspected acute mesenteric ischemia (AMI). CT imaging can potentially differentiate between reversible and irreversible ischaemic damage of the bowel. This moment is pivotal in selecting the treatment strategy for AMI - in the absence of irreversible damage; reperfusion thera…
Computed tomography (CT) is the standard modality for scanning patients with critical acute abdominal conditions, including suspected acute mesenteric ischemia (AMI). CT imaging can potentially differentiate between reversible and irreversible ischaemic damage of the bowel. This moment is pivotal in selecting the treatment strategy for AMI - in the absence of irreversible damage; reperfusion therapy can preserve intestinal viability, thereby avoiding the need for bowel resection. The present study tests the hypothesis that combining several symptoms may enhance the diagnostic performance of CT scanning in detecting salvageable bowel in patients with AMI. This study is an ancillary component of the AMESI study (Clinical Trials: NCT05218863) - a prospective, multicentre observational study aimed at identifying the incidence and describing the outcomes of acute mesenteric ischemia (AMI) in adult hospitalized patients. The ultimate purpose of the present study is to create a computed tomography-based radiological score for the assessment of bowel viability in patients with AMI.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Participant in AMESI study
* confirmed or suspected acute mesenteric ischaemia
* CT scan of the entire abdominal cavity / full body using intravenous contrast media is available
Exclusion Criteria:
* Scans without the use of an intravenous contrast media or those covering on…
Inclusion Criteria:
* Participant in AMESI study
* confirmed or suspected acute mesenteric ischaemia
* CT scan of the entire abdominal cavity / full body using intravenous contrast media is available
Exclusion Criteria:
* Scans without the use of an intravenous contrast media or those covering only a partial area of the abdomen will be excluded.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.